Cepheid readies FDA filing for test that detects coronavirus, influenza A & B, RSV

2020 04 04 00 34 1763 Lab Test Antibody 400

Danaher's Cepheid has developed a combination test that can detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus (RSV) in a single sample.

The Xpert Xpress SARS-CoV-2/flu/RSV four-in-one test can be used on the company's GeneXpert Systems, which can be configured for point-of-care and high-volume lab testing. Results are delivered within 35 minutes, according to Cepheid.

Cepheid will seek an emergency use authorization for the test from the U.S. Food and Drug Administration in the coming weeks.

Page 1 of 7
Next Page